NN1952

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NN1952, covering 2017-07-25 to 2017-07-25. Get the full timeline:

Most recent: Clinical Trial Update: A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes [Phase 1]